Sangamo Announces Capsid License Agreement with Lilly to Delivery Genomic Medicines for Diseases of the Central Nervous System

ASGCT 2023

Epigenetic Regulation for Neurology
Viral Delivery for Neurology
Genomic Engineering Platform Evolution
Assays to Support Clinical Programs